risedronic acid has been researched along with Celiac Disease in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Celiac Disease: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dogru, T | 1 |
| Sonmez, A | 1 |
| Tasci, I | 1 |
| Genc, H | 1 |
1 other study available for risedronic acid and Celiac Disease
| Article | Year |
|---|---|
Symptomatic hypocalcemia due to oral risedronate therapy.
Topics: Adult; Bone Density Conservation Agents; Celiac Disease; Etidronic Acid; Humans; Hypocalcemia; Male; | 2005 |